{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:24:33Z","timestamp":1782483873854,"version":"3.54.5"},"reference-count":62,"publisher":"JLE","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.nephro.2017.01.012","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T06:15:34Z","timestamp":1496297734000},"page":"S75-S81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S1","title":["Glom\u00e9rulon\u00e9phrite extramembraneuse\u00a0: m\u00e9canismes et histoire naturelle"],"prefix":"10.1684","volume":"13","author":[{"given":"Barbara","family":"Seitz-Polski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Lambeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Esnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"issue":"3","key":"10.1016\/j.nephro.2017.01.012_bib0315","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1523-1755.2004.00834.x","article-title":"Epidemiologic data of primary glomerular diseases in western France","volume":"66","author":"Simon","year":"2004","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.nephro.2017.01.012_bib0320","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.nephro.2017.01.012_bib0325","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM199307083290203","article-title":"Prognosis of untreated patients with idiopathic membranous nephropathy","volume":"329","author":"Schieppati","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.nephro.2017.01.012_bib0330","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1600-6143.2008.02237.x","article-title":"Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study","volume":"8","author":"Dabade","year":"2008","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.nephro.2017.01.012_bib0335","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1093\/ndt\/gfq223","article-title":"Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN)","volume":"25","author":"Moroni","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJMe0903343","article-title":"Human idiopathic membranous nephropathy--a mystery solved?","volume":"361","author":"Glassock","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nephro.2017.01.012_bib0345","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-100-24736","article-title":"Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions","volume":"100","author":"Heymann","year":"1959","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1980.1","article-title":"In situ immune complex formation and glomerular injury","volume":"17","author":"Couser","year":"1980","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.nephro.2017.01.012_bib0355","first-page":"287","article-title":"Characterization of the antigen (gp600) of Heymann nephritis","volume":"50","author":"Makker","year":"1984","journal-title":"Lab Invest"},{"issue":"4909","key":"10.1016\/j.nephro.2017.01.012_bib0360","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.2786251","article-title":"Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor","volume":"244","author":"Raychowdhury","year":"1989","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.nephro.2017.01.012_bib0365","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1073\/pnas.91.21.9725","article-title":"Complete cloning and sequencing of rat gp330\/\u201cmegalin\u201d a distinctive member of the low density lipoprotein receptor gene family","volume":"91","author":"Saito","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.nephro.2017.01.012_bib0370","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4049\/jimmunol.137.5.1511","article-title":"The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy","volume":"137","author":"Cybulsky","year":"1986","journal-title":"J Immunol"},{"issue":"26","key":"10.1016\/j.nephro.2017.01.012_bib0375","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.nephro.2017.01.012_bib0385","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.nephro.2017.01.012_bib0390","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMc1003066","article-title":"PLA2R autoantibodies and recurrent membranous nephropathy after transplantation","volume":"363","author":"Stahl","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.nephro.2017.01.012_bib0395","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMc1011678","article-title":"PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.nephro.2017.01.012_bib0400","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.nephro.2017.01.012_bib0405","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1681\/ASN.2015101155","article-title":"Phospholipase A2 receptor-related membranous nephropathy and mannan-binding lectin deficiency","volume":"27","author":"Bally","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0410","doi-asserted-by":"crossref","first-page":"c10","DOI":"10.1159\/000112466","article-title":"Familial membranous nephropathy: an X-linked genetic susceptibility?","volume":"108","author":"Bockenhauer","year":"2008","journal-title":"Nephron Clin Pract"},{"issue":"7","key":"10.1016\/j.nephro.2017.01.012_bib0415","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.nephro.2017.01.012_bib0420","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/gene.2014.50","article-title":"PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes","volume":"15","author":"Saeed","year":"2014","journal-title":"Genes Immun"},{"issue":"4","key":"10.1016\/j.nephro.2017.01.012_bib0425","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.2012070730","article-title":"Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy","volume":"24","author":"Coenen","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"10.1016\/j.nephro.2017.01.012_bib0430","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2017.01.012_bib0435","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.biochi.2015.08.007","article-title":"Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy","volume":"118","author":"Seitz-Polski","year":"2015","journal-title":"Biochimie"},{"issue":"7","key":"10.1016\/j.nephro.2017.01.012_bib0440","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1172\/JCI85265","article-title":"Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy","volume":"126","author":"Tomas","year":"2016","journal-title":"J Clin Invest"},{"issue":"22","key":"10.1016\/j.nephro.2017.01.012_bib0445","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","article-title":"Early-childhood membranous nephropathy due to cationic bovine serum albumin","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nephro.2017.01.012_bib0450","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1681\/ASN.2013030290","article-title":"Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy","volume":"25","author":"Debiec","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.nephro.2017.01.012_bib0455","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.semnephrol.2010.09.011","article-title":"Membranous nephropathy and malignancy","volume":"30","author":"Beck","year":"2010","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.1016\/j.nephro.2017.01.012_bib0460","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1542\/peds.2010-3137","article-title":"Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy","volume":"128","author":"Liao","year":"2011","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.nephro.2017.01.012_bib0465","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM197309062891007","article-title":"Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome","volume":"289","author":"Costanza","year":"1973","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.nephro.2017.01.012_bib0470","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMc1511702","article-title":"A mechanism for cancer-associated membranous nephropathy","volume":"374","author":"Hoxha","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nephro.2017.01.012_bib0475","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2016010050","article-title":"An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy","volume":"28","author":"Hoxha","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.nephro.2017.01.012_bib0480","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.ajkd.2011.10.044","article-title":"Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis","volume":"59","author":"Gunnarsson","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.nephro.2017.01.012_bib0485","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1053\/j.ajkd.2013.07.019","article-title":"Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy","volume":"62","author":"Timmermans","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.nephro.2017.01.012_bib0490","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.nephro.2017.01.012_bib0495","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrneph.2012.35","article-title":"Pathogenesis of membranous nephropathy: recent advances and future challenges","volume":"8","author":"Ronco","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.nephro.2017.01.012_bib0500","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/ndt\/gfu252","article-title":"Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients","volume":"29","author":"Seitz-Polski","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.nephro.2017.01.012_bib0505","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.nephro.2017.01.012_bib0510","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0896-8411(90)90142-F","article-title":"Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum","volume":"3","author":"Sabbaga","year":"1990","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.nephro.2017.01.012_bib0515","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI117371","article-title":"Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo","volume":"94","author":"Kramers","year":"1994","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.nephro.2017.01.012_bib0520","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ki.1997.365","article-title":"Lupus nephritis","volume":"52","author":"Berden","year":"1997","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.nephro.2017.01.012_bib0525","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"Hoxha","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.nephro.2017.01.012_bib0530","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.nephro.2017.01.012_bib0535","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/j.1600-6143.2011.03643.x","article-title":"Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy","volume":"11","author":"Debiec","year":"2011","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.nephro.2017.01.012_bib0540","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/TP.0000000000000630","article-title":"Antiphospholipase A2 receptor antibody levels predict the risk of posttransplantation recurrence of membranous nephropathy","volume":"99","author":"Quintana","year":"2015","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.nephro.2017.01.012_bib0545","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/ajt.13133","article-title":"Anti-phospholipase A(2) receptor antibodies in recurrent membranous nephropathy","volume":"15","author":"Kattah","year":"2015","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.nephro.2017.01.012_bib0550","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.nephro.2017.01.012_bib0555","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1084\/jem.20022031","article-title":"The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem)","volume":"197","author":"Li","year":"2003","journal-title":"J Exp Med"},{"issue":"15","key":"10.1016\/j.nephro.2017.01.012_bib0560","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1074\/jbc.270.15.8963","article-title":"The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization","volume":"270","author":"Ancian","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0565","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1074\/jbc.271.1.250","article-title":"Endocytic properties of the M-type 180-kDa receptor for secretory phospholipases A2","volume":"271","author":"Zvaritch","year":"1996","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.nephro.2017.01.012_bib0570","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1681\/ASN.2013121315","article-title":"Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy","volume":"26","author":"Kao","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.nephro.2017.01.012_bib0575","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy","volume":"26","author":"Fresquet","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.nephro.2017.01.012_bib0580","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1681\/ASN.2014111061","article-title":"Epitope spreading of autoantibody response to PLA2R Associates with poor prognosis in membranous nephropathy","volume":"27","author":"Seitz-Polski","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0585","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1681\/ASN.V11157","article-title":"A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease","volume":"11","author":"Oleinikov","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.nephro.2017.01.012_bib0590","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.4049\/jimmunol.172.4.2367","article-title":"Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis","volume":"172","author":"Tramontano","year":"2004","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.nephro.2017.01.012_bib0595","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1681\/ASN.2007030342","article-title":"Intramolecular epitope spreading in Heymann nephritis","volume":"18","author":"Shah","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"9337","key":"10.1016\/j.nephro.2017.01.012_bib0600","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.nephro.2017.01.012_bib0605","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1681\/ASN.2014070640","article-title":"Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy","volume":"26","author":"Ruggenenti","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0610","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.ki.5002628","article-title":"Rituximab treatment of idiopathic membranous nephropathy","volume":"73","author":"Fervenza","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0615","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1681\/ASN.2016040449","article-title":"Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up","volume":"28","author":"Dahan","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.nephro.2017.01.012_bib0310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.critrevonc.2006.09.004","article-title":"Pharmacokinetics of rituximab and its clinical use: thought for the best use?","volume":"62","author":"Cartron","year":"2007","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517300366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517300366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2017.01.012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:41:47Z","timestamp":1741192907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725517300366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":62,"alternative-id":["S1769725517300366"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2017.01.012","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glom\u00e9rulon\u00e9phrite extramembraneuse\u00a0: m\u00e9canismes et histoire naturelle","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2017.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}